Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations
| Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations |
| Autore | Ruaro Barbara |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (178 p.) |
| Soggetto topico |
Medicine and Nursing
Pharmacology |
| Soggetto non controllato |
3D-echocardiography
airway disease antifibrotic agents cardiopulmonary exercise testing connective tissue diseases COVID-19 CX3CL1/fractalkine CX3CR1 diffuse alveolar hemorrhage efficacy fibromyalgia gastrointestinal symptoms heart failure high-resolution computed tomography infection inflammatory response interstitial lung disease interstitial lung diseases IPF M1 macrophage M2 macrophage microvascular involvement nailfold capillaroscopy osteopontin outcome pharmacological interactions pleurisy PMR polymyalgia rheumatica probiotic progressive fibrosing ILD pulmonary arterial hypertension pulmonary function tests pulmonary involvement rheumatic rheumatoid arthritis scleroderma shrinking lung syndrome SKG mice systemic lupus erythematosus systemic sclerosis t-vns targeted therapy tolerability UIP vagus nerve stimulation ventricular function ventricular-arterial coupling VSL#3® |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Rheumatic Diseases |
| Record Nr. | UNINA-9910566486303321 |
Ruaro Barbara
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Rheumatoid Arthritis Therapy Reappraisal : Strategies, Opportunities and Challenges
| Rheumatoid Arthritis Therapy Reappraisal : Strategies, Opportunities and Challenges |
| Autore | Müller Rüdiger |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (260 p.) |
| Soggetto topico | Medicine and Nursing |
| Soggetto non controllato |
ACR response
adenosine ankylosing spondylitis anti-citrullinated protein autoantibodies anti-TNF baricitinib bioavailability biosimilar certolizumab pegol computed tomography csDMARDs cytokine DAS 28 disease-modifying antirheumatic drugs DMARD effectiveness efficacy fatigue foot fracture fracture risk assessment tool glucocorticoids golimumab hand HAQ-DI herbal medicine IFN-γ, CD73 IL-17A immunogenicity infliximab intra-articular injections magnetic resonance imaging matrix metalloproteinase 3 medication methotrexate methylation MTX n/a next-generation sequencing oral oral route osteoclast osteoporosis outcomes research pain pain perception patient perspective periodontal disease periodontitis personalized medicine pharmacogenomics Porphyromonas gingivalis posology productivity pseudoerosions psoriatic arthritis radiography recovery of function regulation rheumatoid arthritis Rheumatoid arthritis Rheumatoid Arthritis rheumatoid factor sleep sleep disorders smoking subcutaneous route switching synovial fibroblasts Th1.17 therapy titration TNFα tofacitinib tolerability treat-to-target Tumor Necrosis Factor-Alpha Inhibitors ultrasonography |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Rheumatoid Arthritis Therapy Reappraisal |
| Record Nr. | UNINA-9910557286503321 |
Müller Rüdiger
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||